Sudarshan Chemical Industries Ltd

- Sudarshan Chemical Industries is focusing on cost reduction and value capture initiatives across operations, procurement, organization, IT, and fixed costs, aiming for EUR 90-100 million EBITDA in 3-4 years. - The company has inaugurated a Global Capability Center (GCC) on February 4, 2026, aiming to ramp up operations over the next year and improve productivity and response time via digital innovation. - There is a major initiative to harmonize multiple SAP systems into one by December 2026, enhancing efficiency by simplifying invoicing and process integration. - Manufacturing footprint rationalization has been largely completed, such as rightsizing Frankfurt operations and transferring production to India; no further major manufacturing changes planned. - Inventory liquidation is underway to reduce working capital and net debt, with expected positive balance sheet impact but short-term P&L impact due to overhead absorption. - No explicit mention of new capital expenditure on production capacity expansion, focusing more on operational optimization and integration.

- Legacy Sudarshan business: Expected to return to its long-term growth rate of around 10-11% CAGR, with growth resuming from Q4 FY '26 onwards. - Acquired business (Heubach): Anticipated sales growth after inventory destocking phase; production volumes will initially lag sales, normalizing post-Q2 FY '27. - Demand Improvement: Customers showed subdued demand in first 7-8 months but demand improved substantially after November, indicating recovery. - New product investments in legacy business are performing well, with growing demand and potential margin improvements. - Overall revenue growth is expected to be gradual and back-ended with a ramp-up as cost optimization and synergies take effect. - Industry-wide demand challenges are seen as temporary; normal buying patterns expected to resume, supporting volume growth.

- Legacy Sudarshan business is expected to return to a long-term sustainable growth rate of around 10%-11% CAGR (Rajesh Rathi, Page 13). - The company anticipates gradual improvement in operating performance with cost optimization and working capital initiatives, resulting in building up to ~10% margin or close to EUR 90-100 million EBITDA over the next few years (Page 14). - Synergies and cost savings pipeline is strong, with a 3-4 year target to deliver EUR 90-100 million EBITDA largely through cost reduction and normalized sales (Page 9). - The impact of inventory reduction (EUR 30-40 million reduction) will positively affect cash flow and net debt but may temporarily suppress reported EBITDA by EUR 9-12 million over the next 3 quarters, normalizing thereafter (Page 6-7). - Confident of improved profitability from Q4 FY26 onwards supported by customer restocking and demand recovery (Page 14). - EPS was negative INR 1.4 in the reported period but outlook is positive with margin expansion and demand normalization (Page 6).

- Management expressed confidence in demand improvement starting January and early February, indicating a positive trend in order inflow. - Customers had promised to start buying after January, reflecting an uptick in orderbook. - The subdued demand in prior quarters was mainly due to customer destocking rather than weak end-market orders. - There is no explicit mention of a large existing order backlog or pending orders; confidence seems based on renewed customer buying behavior and market recovery. - The company expects demand normalization, supported by customer trust and improved supply chain processes. - Overall, orderbook visibility appears positive for Q4 FY26 and beyond, driven by genuine demand recovery rather than one-time restocking.

- The transcript does not explicitly mention any current or planned new fundraising through debt or equity. - Rajesh Rathi and other management highlighted focus on reducing net debt by liquidating inventory of EUR 30-40 million, which should improve balance sheet and reduce working capital. - Interest cost on borrowings is currently around 5.75% to 6% (excluding IndAS lease accounting costs). - No specific mention of any equity issuance or debt refinancing plans. - Management is focused on cost optimization, working capital improvements, and operational efficiencies to improve financial metrics rather than relying on new capital raising at this point.